Results 31 to 40 of about 288,150 (296)

Surgical treatment of intraperitoneal metastases from lung cancer: two case reports and a review of the literature

Journal of Medical Case Reports, 2019
Background Peritoneal metastases are often reported in several abdominal tumors. Peritoneal diffusion from extra-abdominal tumors is thought to be rare. Lung cancer is one of the most common cancers in the world with early metastases and it is associated
Simone Sibio, Giuseppe Sigismondo Sica, Sara Di Carlo, Maurizio Cardi, Alessandra Di Giorgio, Bianca Maria Sollazzo, Paolo Sammartino   +6 more
doaj   +1 more source

Intraperitoneal injection of class A TLR9 agonist enhances anti–PD-1 immunotherapy in colorectal peritoneal metastases

JCI Insight, 2022
Peritoneal metastases are associated with a low response rate to immune checkpoint blockade (ICB) therapy. The numbers of peritoneal resident macrophages (PRMs) are reversely correlated with the response rate to ICB therapy. We have previously shown that
Ting Jiang, Hongji Zhang, Yiming Li, Preethi Jayakumar, Hong Liao, Hai Huang, Timothy R. Billiar, Meihong Deng   +7 more
doaj   +1 more source

Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. [PDF]

PLoS ONE, 2012
In radically resected gastric cancer the possibility to predict the site of relapse could be clinically relevant for the selection of post-surgical management.
Mario Scartozzi, Cristian Loretelli, Eva Galizia, Alessandra Mandolesi, Mirco Pistelli, Alessandro Bittoni, Riccardo Giampieri, Luca Faloppi, Maristella Bianconi, Michela Del Prete, Francesca Bianchi, Laura Belvederesi, Italo Bearzi, Stefano Cascinu   +13 more
doaj   +1 more source

Incidence, Treatment, and Survival of Synchronous Peritoneal Metastases in Pancreatic Cancer:Update of a Nationwide Cohort

, 2021
Objective The aim of the study was to gain insight in the incidence, treatment, and survival of patients with synchronous pancreatic peritoneal metastases.
de Vos-Geelen, J., Besselink, M.G., Anouk Rijken, Felice N. van Erning, Rijken, A., Lemmens, V.E., de Hingh, I.H.J.T., Bakkers, C., van der Geest, L.G., Marc G. Besselink, Checca Bakkers, van Erning, F.N., Judith de Vos-Geelen, Ignace H.J.T. de Hingh, Lydia G. van der Geest, Valery E. Lemmens   +15 more
core   +1 more source

Role of Peritoneal Mesothelial Cells in the Progression of Peritoneal Metastases

Cancers, 2022
Peritoneal metastatic cancer comprises a heterogeneous group of primary tumors that originate in the peritoneal cavity or metastasize into the peritoneal cavity from a different origin. Metastasis is a characteristic of end-stage disease, often indicative of a poor prognosis with limited treatment options. Peritoneal mesothelial cells (PMCs) are a thin
Junliang Li, Tiankang Guo
openaire   +2 more sources

Epidemiological Study of New Cases of Peritoneal Metastases

Zhongliu Fangzhi Yanjiu, 2022
Peritoneal metastases (PM) are defined as the primary or secondary occurrence/progression of malignant tumor in peritoneum. PM were previously thought to be a terminal disease without effective treatment, with short survival and poor prognosis.
YANG Rui, SU Yandong, MA Ru, AN Songlin, LIN Yulin, LI Yan   +5 more
doaj   +1 more source

Detection of Experimental Colorectal Peritoneal Metastases by a Novel PDGFRβ-Targeting Nanobody [PDF]

, 2022
Peritoneal metastases in colorectal cancer (CRC) belong to Consensus Molecular Subtype 4 (CMS4) and are associated with poor prognosis. Conventional imaging modalities, such as Computed Tomography (CT) and Fluorodeoxyglucose-Positron Emission Tomography (
Sjoerd Elias, Inne Borel Rinkes, Guus van Scharrenburg, Kaisa Luoto, Strating, Esther, André Verheem, Elias, Sjoerd, Borel Rinkes, Inne, Steen, Herman, Kranenburg, Onno, Luoto, Kaisa, Verheem, André, van Scharrenburg, Guus, Esther Strating, Herman Steen, Onno Kranenburg, Regenerative Medicine and Stem Cells, Epi Kanker Team C, Lab Translational Oncology, JC onderzoeksprogramma Cancer, MS CGO, Cancer   +21 more
core   +1 more source

Peritoneal regression grading score (PRGS) in peritoneal metastasis: how many biopsies should be examined?

Pleura and Peritoneum, 2022
The four-tied peritoneal regression grading score (PRGS) is increasingly used to evaluate the response of peritoneal metastases (PM) to chemotherapy. The minimal number of peritoneal biopsies needed for PRGS determination remains unclear.
Solass Wiebke, Meisner Christoph, Kurtz Florian, Nadiradze Giorgi, Reymond Marc A., Bösmüller Hans   +5 more
doaj   +1 more source

AIF1+CSF1R+ MSCs, induced by TNF‐α, act to generate an inflammatory microenvironment and promote hepatocarcinogenesis

Hepatology, EarlyView., 2022
Mesenchymal stem cells subset, educated by TNF‐α, are involved to generate inflammatory microenvironment and promote hepatocarcinogenesis Abstract Background and Aims Increasing evidence suggests that mesenchymal stem cells (MSCs) home to injured local tissues and the tumor microenvironment in the liver.
Chen Zong, Yan Meng, Fei Ye, Xue Yang, Rong Li, Jinghua Jiang, Qiudong Zhao, Lu Gao, Zhipeng Han, Lixin Wei   +9 more
wiley   +1 more source

Successful treatment of peritoneal recurrence after gastric cancer surgery with intravenous and intraperitoneal paclitaxel combined with S-1 chemotherapy: a case report

Surgical Case Reports, 2020
Background Despite recent advances in systemic chemotherapy, the prognosis of patients with peritoneal metastases from gastric cancer still remains poor.
Kozo Miyatani, Wataru Miyauchi, Yusuke Kono, Yuji Shishido, Joji Watanabe, Takehiko Hanaki, Kyoichi Kihara, Tomoyuki Matsunaga, Manabu Yamamoto, Yoji Fukumoto, Naruo Tokuyasu, Shuichi Takano, Teruhisa Sakamoto, Soichiro Honjo, Toshimichi Hasegawa, Yoshiyuki Fujiwara   +15 more
doaj   +1 more source